ALNYLAM PHARMACEUTICALS, INC. Current Liabilities 2009-2025 | ALNY
What is current liabilities?
Current liabilities are obligations expected to be settled within one year or the normal operating cycle of the business.
What is ALNYLAM PHARMACEUTICALS, INC.'s current current liabilities?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual current liabilities for 2025 was $1.47B, a 23.61% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. current liabilities for the quarter ending December 31, 2025 was $1.47B.
What was ALNYLAM PHARMACEUTICALS, INC.'s current liabilities in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual current liabilities for 2024 was $1.19B, a 22.58% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s current liabilities in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual current liabilities for 2023 was $967.8M, a 26.03% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year current liabilities CAGR?
ALNYLAM PHARMACEUTICALS, INC. current liabilities grew at a compound annual growth rate (CAGR) of 20.16% from FY2020 to FY2025, going from $585.3M to $1.47B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $1.47B | +23.6% | 10-K |
| FY2024 | $1.19B | +22.6% | 10-K |
| FY2023 | $967.8M | +26.0% | 10-K |
| FY2022 | $767.9M | +10.4% | 10-K |
| FY2021 | $695.7M | +18.9% | 10-K |
| FY2020 | $585.3M | +66.0% | 10-K |
| FY2019 | $352.6M | +96.4% | 10-K |
| FY2018 | $179.5M | +24.4% | 10-K |
| FY2017 | $144.3M | +9.5% | 10-K |
| FY2016 | $131.7M | +112.1% | 10-K |
| FY2015 | $62.1M | -34.9% | 10-K |
| FY2014 | $95.3M | +77.0% | 10-K |
| FY2013 | $53.9M | +11.4% | 10-K |
| FY2012 | $48.3M | -40.3% | 10-K |
| FY2011 | $81.0M | -20.6% | 10-K |
| FY2010 | $102.0M | -7.8% | 10-K |
| FY2009 | $110.7M | - | 10-K |